Christine A. F

Oct 13, 2023 | alzres.biomedcentral.com | von Arnim |Christine A. F |Biomarker Laboratory

Traditionally, AD diagnosis was based solely on clinical criteria; however, current guidelines for AD diagnosis also consider the presence of biologic markers. For the neuropathologic diagnosis of AD using biomarkers, the National Institute on Aging and Alzheimer's Association (NIA-AA) “ATN” research framework can be used [23].